Hao Liu

机构：Rutgers, The State University of New Jersey, Central South University, Guangxi University, Wuhan University, Guangxi University of Chinese Medicine, Renmin Hospital of Wuhan University, Bioengineering Center, Bio-Medical Science (South Korea), Second Xiangya Hospital of Central South University, Rutgers Cancer Institute, Chongqing Medical University · ORCID：0000-0001-6338-4003

发表论文 122 篇 · 总被引 4279 次 · h-index 36

代表论文

• Racial disparities in staging, treatment, and mortality in non-small cell lung cancer (2024 · Translational Lung Cancer Research · 被引 15)
• Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis (2024 · Cellular Signalling · 被引 14)
• Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo (2023 · Biological Procedures Online · 被引 9)
• The TGFβ2‐Snail1‐miRNATGFβ2 Circuitry is Critical for the Development of Aggressive Functions in Breast Cancer (2024 · Clinical and Translational Medicine · 被引 6)
• Comparing the rate of immunotherapy treatment change due to toxicity by sex (2024 · Cancer Reports · 被引 5)
• PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis (2025 · Cellular and Molecular Life Sciences · 被引 2)